<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04305639</url>
  </required_header>
  <id_info>
    <org_study_id>IstanbulMU4</org_study_id>
    <nct_id>NCT04305639</nct_id>
  </id_info>
  <brief_title>The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)&quot;</brief_title>
  <official_title>The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istanbul University-Cerrahpasa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istanbul Medeniyet University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Dyspnea-ALS-Scale (DALS-15) is a uni-dimensional scale to measure dyspnea in patients
      with Amyotrophic Lateral Sclerosis. It can be easily and rapidly applied. The aim of this
      study is to investigate reliability and validity of Turkish version of the DALS-15.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Dyspnea-ALS-Scale (DALS-15)</measure>
    <time_frame>10 minutes</time_frame>
    <description>The scale is used to measure dyspnea in ALS patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Borg Scale</measure>
    <time_frame>10 minutes</time_frame>
    <description>A 10 point Modified Borg Scale is used to assess dyspnea in supine and standing positions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)</measure>
    <time_frame>15 minutes</time_frame>
    <description>It is used to assess functional stats in ALS patients. This study particularly focus on pulmonary functions and dyspnea subscale of the scale.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>Dyspnea</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are diagnosed with Amyothrophic Lateral Sclerosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18 or above

          -  Dyspnea on exertion, dyspnea at rest, or orthopnea without evidence of pulmonary or
             cardiac causes of dyspnea

        Exclusion Criteria:

          -  Severe cognitive dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ESMA NUR KOLBAŞI, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Medeniyet University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ESMA NUR KOLBAŞI, MSc</last_name>
    <phone>+902162883333</phone>
    <email>esmanur.kolbasi@medeniyet.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gökşen Kuran Aslan, PhD</last_name>
    <email>goksenkuran@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istanbul Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34700</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>ESMA NUR KOLBAŞI, PI</last_name>
      <email>esmanur.kolbasi@medeniyet.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 10, 2020</study_first_submitted>
  <study_first_submitted_qc>March 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medeniyet University</investigator_affiliation>
    <investigator_full_name>Esma Nur KOLBAŞI</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

